loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Erdosteine

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Erdosteine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 119Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Recipharm’s Erdosteine to be Tested for COVID-19 Treatment
    Recipharm’s Erdosteine to be Tested for COVID-19 Treatment

    08 Apr 2020

    // RECIPHARM

    https://www.recipharm.com/press/recipharm%E2%80%99s-proprietary-molecule-erdosteine-be-tested-part-covid-19-treatment

    RECIPHARM
    08 Apr 2020
    Share Share
    Recipharm’s proprietary molecule Erdosteine recognised as COPD treatment
    Recipharm’s proprietary molecule Erdosteine recognised as COPD treatment

    23 Nov 2018

    // MANUFACTURING

    https://www.manufacturingchemist.com/news/article_page/Recipharms_proprietary_molecule_Erdosteine_recognised_as_COPD_treatment/149413

    MANUFACTURING
    23 Nov 2018
    Share Share
    Recipharm Signs 10-Year Extension for Daewoong Pharma API
    Recipharm Signs 10-Year Extension for Daewoong Pharma API

    10 Nov 2015

    // PHARMACEUTICAL MANUFACTURING

    http://www.pharmamanufacturing.com/industrynews/2015/recipharm-signs-10-year-extension-for-daewoong-pharma-api/

    PHARMACEUTICAL MANUFACTURING
    10 Nov 2015
    Share Share